欧洲慢性胰腺炎基于形态的手术治疗:迈向新一代统一指南
该研究基于ESCORA前瞻性多中心队列的事后分析,纳入13国22中心207例慢性胰腺炎手术患者,评估指南依从性与预后。结果显示90天死亡率1.4%,6个月疼痛缓解率72.6%,手术方式随形态亚型差异显著,指南依从手术未改善主要并发症、死亡率或疼痛缓解。
要点
- 慢性胰腺炎手术方式随形态亚型显著不同,指南依从率66%。
- 指南依从手术未显著改善主要并发症、死亡率或疼痛缓解。
- 欧洲实践差异大,尤其小胰管病中正式及V形胰腺切除术的使用。
核心结论
- 欧洲慢性胰腺炎手术实践存在显著差异,亟需统一指南明确推荐,尤其针对正式及V形胰腺切除术。
研究设计与样本
- ESCOPA前瞻性多中心研究的事后分析,纳入13国22中心207例慢性胰腺炎手术患者,随访6个月。
主要发现
- 90天死亡率为1.4%,6个月疼痛缓解率为72.6%。
- 联合主胰管扩张与胰头增大者行保留十二指肠胰头切除术最多(46.8%,P=0.016)。
- 孤立主胰管扩张者以正式胰腺切除术为主(63.3%,P=0.040),小胰管病者亦然(66.0%,P=0.004)。
- 指南依从手术(66%)与主要并发症(12.9% vs. 18.8%,P=0.387)、死亡率(1.6% vs. 1.6%,P>0.999)及疼痛缓解(75.3% vs. 66.7%,P=0.468)无显著关联。
- 引流/保留实质手术与正式胰腺切除术的结局相当。
关键数值与推荐
- 按形态亚型分层:孤立主胰管扩张、孤立胰头增大、联合主胰管扩张与胰头增大、小胰管病。
- 治疗依据欧洲HaPanEU及国际IAP-APA-JPS-EPC指南。
临床怎么用
- 临床决策需考虑形态亚型,但指南依从手术未显示结局优势。
- 欧洲实践差异提示需统一指南,尤其对小胰管病的术式选择。
局限性
- 事后分析设计可能引入选择偏倚。
- 样本量207例,随访仅6个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the use and impact of current surgical guidelines for chronic pancreatitis (CP) across Europe. SUMMARY BACKGROUND DATA: Current guidelines recommend morphology-based surgery for CP, but international studies evaluating their use and impact are lacking. METHODS: Post hoc analysis of the prospective multicenter ESCOPA study, including patients undergoing surgery for symptomatic CP at 22 centers in 13 countries (June 2021-November 2022), with 6-month follow-up. Patients were stratified by morphologic subtype: "isolated dilated main pancreatic duct (MPD)," "isolated enlarged pancreatic head (PH)," "combined dilated MPD and enlarged PH," and "small duct disease." Treatment was based on the European HaPanEU and International IAP-APA-JPS-EPC guidelines. Primary outcomes were 90-day major morbidity, mortality, and pain relief at 6 months. Practice variation was assessed, including a case-based survey. RESULTS: Overall, 207 patients were included following surgery for CP, with 1.4% 90-day mortality and 72.6% pain relief. The surgical approach varied widely by morphologic subtype: duodenum-preserving pancreatic head resections (DPPHR) were most common for "combined dilated MPD and enlarged PH" (46.8%, P=0.016); whereas formal pancreatectomy predominated for "isolated dilated MPD" (63.3%, P=0.040) and "small duct disease" (66.0%, P=0.004). Guideline-concordant surgery (66%) was not associated with improved rates of major morbidity (12.9% vs. 18.8%, P=0.387), mortality (1.6% vs. 1.6%, P>0.999), or pain relief (75.3% vs. 66.7%, P=0.468). Outcomes were also comparable between drainage/parenchyma-preserving surgery and formal pancreatectomy. Survey findings confirmed practice variation, including the use of formal and V-shaped pancreatectomy for small duct disease. CONCLUSION: The substantial variation in surgical practice for CP across Europe highlights the need for unified guidelines with clear recommendations, particularly regarding formal and V-shaped pancreatectomy.
引用
- Van Veldhuisen CL, Leseman CA, De Rijk FEM, et al. Morphology-Based Surgery for Chronic Pancreatitis Across Europe: Toward the Next Generation of Unified Guidelines. Ann Surg. 2026. PMID: 42693506. doi:10.1097/SLA.0000000000007202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。